Cargando…

ERG Protein Expression Is of Limited Prognostic Value in Men with Localized Prostate Cancer

Background. The prognostic significance of ERG expression in prostate cancer (PCA) has generated mixed results. We sought to investigate the prognostic significance of ERG expression in a localized cohort of men with PCA. Material and Methods. We investigated ERG protein expression in a cohort of 19...

Descripción completa

Detalles Bibliográficos
Autores principales:	Teng, Liang Hong, Wang, Cheng, Dolph, Michael, Donnelly, Bryan, Bismar, Tarek A.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi Publishing Corporation 2013
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3762160/ https://www.ncbi.nlm.nih.gov/pubmed/24027643 http://dx.doi.org/10.1155/2013/786545

Ejemplares similares

Cysteine- rich secretory protein 3 (CRISP3), ERG and PTEN define a molecular subtype of prostate cancer with implication to patients’ prognosis
por: Al Bashir, Samir, et al.
Publicado: (2014)

The significance of dynamin 2 expression for prostate cancer progression, prognostication, and therapeutic targeting
por: Xu, Bin, et al.
Publicado: (2014)

The Expression of Proto-Oncogene ETS-Related Gene (ERG) Plays a Central Role in the Oncogenic Mechanism Involved in the Development and Progression of Prostate Cancer
por: Khosh Kish, Ealia, et al.
Publicado: (2022)

Comprehensive study on ERG gene expression in normal karyotype acute myeloid leukemia: ERG expression is of limited prognostic value, whereas the accumulation of adverse prognostic markers stepwise worsens the prognosis
por: Weber, S, et al.
Publicado: (2016)

ERG oncoprotein expression in prostate cancer: clonal progression of ERG-positive tumor cells and potential for ERG-based stratification
por: Furusato, B, et al.
Publicado: (2010)

Expression of ERG Protein and TMRPSS2-ERG Fusion in Prostatic Carcinoma in Egyptian Patients
por: Abdel-Hady, Ahmed, et al.
Publicado: (2017)

Prognostic value of ERG, PTEN, CRISP3 and SPINK1 in predicting biochemical recurrence in prostate cancer
por: NOH, BYEONG-JOO, et al.
Publicado: (2016)

Evaluation of ERG Expression in Prostate Adenocarcinoma and Its Prognostic Impact in Patients Survival Rate
por: Moradi Tabriz, Hedieh, et al.
Publicado: (2021)

Mapping Isoform Abundance and Interactome of the Endogenous TMPRSS2-ERG Fusion Protein by Orthogonal Immunoprecipitation–Mass Spectrometry Assays
por: Fu, Zhiqiang, et al.
Publicado: (2021)

The prognostic value of SUMO1/Sentrin specific peptidase 1 (SENP1) in prostate cancer is limited to ERG-fusion positive tumors lacking PTEN deletion
por: Burdelski, Christoph, et al.
Publicado: (2015)

Expression and ERG regulation of PIM kinases in prostate cancer
por: Eerola, Sini K., et al.
Publicado: (2021)

Reconstitution of the ERG Gene Expression Network Reveals New Biomarkers and Therapeutic Targets in ERG Positive Prostate Tumors
por: Dubovenko, Alexey, et al.
Publicado: (2015)

ERG oncoprotein expression in prostatic acinar adenocarcinoma; clinicopathologic significance
por: Hashmi, Atif Ali, et al.
Publicado: (2019)

Editorial: The Application of Proteogenomics to Urine Analysis for the Identification of Novel Biomarkers of Prostate Cancer: An Exploratory Study
por: Gamallat, Yaser, et al.
Publicado: (2023)

α-Catenin expression has prognostic value in local and locally advanced prostate cancer
por: Aaltomaa, S, et al.
Publicado: (1999)

Copy Number Profiles of Prostate Cancer in Men of Middle Eastern Ancestry
por: Albawardi, Alia, et al.
Publicado: (2021)

Cleavage and Polyadenylation-Specific Factor 4 (CPSF4) Expression Is Associated with Enhanced Prostate Cancer Cell Migration and Cell Cycle Dysregulation, In Vitro
por: Choudhry, Muhammad, et al.
Publicado: (2023)

ERG Tumor Type is Less Frequent in High Grade and High Stage Prostate Cancers of Chinese Men
por: Baohong, Jiang, et al.
Publicado: (2019)

5′ UTR Control of Native ERG and of Tmprss2:ERG Variants Activity in Prostate Cancer
por: Zammarchi, Francesca, et al.
Publicado: (2013)

Significance of the TMPRSS2:ERG gene fusion in prostate cancer
por: Wang, Zhu, et al.
Publicado: (2017)

The transcription factor ERG increases expression of neurotransmitter receptors on prostate cancer cells
por: Kissick, Haydn T., et al.
Publicado: (2015)

Prevalence of ERG expression and PTEN loss in a Brazilian prostate cancer cohort
por: Morais, C.E., et al.
Publicado: (2019)

Coordinate MicroRNA-Mediated Regulation of Protein Complexes in Prostate Cancer
por: Alshalalfa, Mohammed, et al.
Publicado: (2013)

Novel Dual Color Immunohistochemical methods for detecting ERG-PTEN and ERG-SPINK1 status in prostate carcinoma
por: Bhalla, Ritu, et al.
Publicado: (2013)

Prognostic value of PTEN loss in men with conservatively managed localised prostate cancer
por: Cuzick, J, et al.
Publicado: (2013)

ERG Deregulation Induces PIM1 Over-Expression and Aneuploidy in Prostate Epithelial Cells
por: Magistroni, Vera, et al.
Publicado: (2011)

TMPRSS2-ERG Expression Predicts Prostate Cancer Survival and Associates with Stromal Biomarkers
por: Hägglöf, Christina, et al.
Publicado: (2014)

Glycyl-tRNA Synthetase (GARS) Expression Is Associated with Prostate Cancer Progression and Its Inhibition Decreases Migration, and Invasion In Vitro
por: Khosh Kish, Ealia, et al.
Publicado: (2023)

Differential expression of hERG1A and hERG1B genes in pediatric acute lymphoblastic leukemia identifies different prognostic subgroups
por: Pillozzi, S, et al.
Publicado: (2014)

Systematic analysis reveals molecular characteristics of ERG-negative prostate cancer
por: Xiao, Qingyu, et al.
Publicado: (2018)

Immunohistochemical Expression of Alpha-Methyl-Coa (AMACR) and ERG in Prostatic Adenocarcinoma and Prostatic Hyperplasia: A Comparative Study
por: Samir Sayed, Rasha Mohamed, et al.
Publicado: (2023)

The ubiquitin ligase TRIM25 targets ERG for degradation in prostate cancer
por: Wang, Shan, et al.
Publicado: (2016)

Prostate cancer genes associated with TMPRSS2–ERG gene fusion and prognostic of biochemical recurrence in multiple cohorts
por: Barwick, B G, et al.
Publicado: (2010)

Oncogenic activation of ERG: A predominant mechanism in prostate cancer
por: Sreenath, Taduru L, et al.
Publicado: (2011)

ERG Immunohistochemistry and Clinicopathologic Characteristics in Korean Prostate Adenocarcinoma Patients
por: Suh, Ja Hee, et al.
Publicado: (2012)

ERG induces taxane resistance in castration-resistant prostate cancer
por: Galletti, Giuseppe, et al.
Publicado: (2014)

Docetaxel Treatment in PTEN- and ERG-aberrant Metastatic Prostate Cancers
por: Rescigno, Pasquale, et al.
Publicado: (2018)

Dynamic Control of ERG20 and ERG9 Expression for Improved Casbene Production in Saccharomyces cerevisiae
por: Callari, Roberta, et al.
Publicado: (2018)

Expression of ERG11, ERG3, MDR1 and CDR1 genes in Candida tropicalis
por: Rojas, Ana Elisa, et al.
Publicado: (2023)

ERG Induces Epigenetic Activation of Tudor Domain-Containing Protein 1 (TDRD1) in ERG Rearrangement-Positive Prostate Cancer
por: Kacprzyk, Lukasz A., et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_ldehlegmncrjfb0ov9tf6l9hdq